The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial
Title:
The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial
Author:
Alvarez Secord, A. Lewin, S.N. Murphy, C.G. Cecere, S.C. Barquín, A. Gálvez-Montosa, F. Mathews, C.A. Konecny, G.E. Ray-Coquard, I. Oaknin, A. Rubio Pérez, M.J. Bonaventura, A. Diver, E.J. Ayuk, S.-M. Wang, Y. Corr, B.R. Salutari, V.